Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | doxorubicin:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.04 | 0.2 |
mRNA | ML258 | CTRPv2 | pan-cancer | AAC | -0.046 | 0.2 |
mRNA | cyanoquinoline 11 | CTRPv2 | pan-cancer | AAC | 0.064 | 0.2 |
mRNA | AZ-3146 | CTRPv2 | pan-cancer | AAC | 0.043 | 0.2 |
mRNA | Compound 7d-cis | CTRPv2 | pan-cancer | AAC | 0.045 | 0.2 |
mRNA | necrostatin-7 | CTRPv2 | pan-cancer | AAC | -0.045 | 0.2 |
mRNA | SCH-79797 | CTRPv2 | pan-cancer | AAC | 0.042 | 0.2 |
mRNA | BRD-K63431240 | CTRPv2 | pan-cancer | AAC | 0.043 | 0.2 |
mRNA | SJ-172550 | CTRPv2 | pan-cancer | AAC | 0.046 | 0.2 |
mRNA | BRD-K88742110 | CTRPv2 | pan-cancer | AAC | 0.043 | 0.3 |